Potassium Channel Tetramerisation Domain Containing 16 (KCTD16) Peptide
KCTD16
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN940007
Quick Overview for Potassium Channel Tetramerisation Domain Containing 16 (KCTD16) Peptide (ABIN940007)
Target
KCTD16
(Potassium Channel Tetramerisation Domain Containing 16 (KCTD16))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- KREAEYFQLP DLVKLLTPDE IKQSPDEFCH SDFEDASQGS DTRICPPSSL
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of KCTD16 antibody,
Alternative Names: KCTD16 control peptide, KCTD16 antibody Blocking Peptide, Anti-KCTD16 Blocking Peptide, Potassium Channel Tetramerisation Domain Containing 16 Blocking Peptide, DKFZp781A1155 Blocking Peptide, KIAA1317 Blocking Peptide, MGC138167 Blocking Peptide, KCTD16, KCTD-16, KCTD 16, KCTD-16 Blocking Peptide, KCTD 16 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- KCTD16 (Potassium Channel Tetramerisation Domain Containing 16 (KCTD16))
-
Background
- KCTD16 is an auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. It increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization.
-
Molecular Weight
- 49 kDa
Target
-
You are here:
